• Community pharmacy contractors can expect more CPCS referrals
    by Shilpa Sharma on January 15, 2022 at 1:35 pm

    Community pharmacy contractors are likely to receive more referrals from NHS 111 for the Community Pharmacist Consultation Service (CPCS) following a review of the NHS Pathway algorithms, NHS England and NHS Improvement (NHSE&I) announced on Friday (January 14). The review, conducted by an expert group of Integrated Urgent Care clinicians and pharmacists, led to inclusion The post Community pharmacy contractors can expect more CPCS referrals first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Community pharmacies deliver over 22 million Covid-19 jabs in one year
    by Shilpa Sharma on January 15, 2022 at 1:26 pm

    Community pharmacies played a central role in the government’s response to the Covid-19 pandemic, delivering more than 22 million jabs in the past 12 months. Besides delivering millions of jabs, latest figures from NHS England and NHS Improvement (NHSE&I) revealed a 50 per cent increase in the number of pharmacies delivering Covid boosters compared from The post Community pharmacies deliver over 22 million Covid-19 jabs in one year first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Exclusive: Government considers extending pharmacy declaration of emergency
    by Isabel Shaw on January 14, 2022 at 11:34 am

    The declaration of emergency which allows the flexible provision of pharmaceutical services may be extended beyond its original end date of 31 January, The Pharmacist has learned.  The measure, which was was initially introduced in March 2020 to help maintain pharmacy services during the Covid-19 pandemic, may be extended as cases across the country remain... Read more The post Exclusive: Government considers extending pharmacy declaration of emergency appeared first on The Pharmacist.

  • Melanie Hamer to leave E4H
    by Emma Morriss on January 14, 2022 at 11:31 am

    Brand commercialisation and pharmaceutical marketing agency, E4H, has announced that Events Director, Melanie Hamer has taken the decision to leave the company in March 2022. Melanie is most known as the driving force behind the successful Pf Awards having grown them from their inception 22 years ago to become the largest pharmaceutical sales awards in

  • Morningside Pharmaceuticals’ Nik Kotecha receives Distinguished Alumni Award by Imperial College London
    by Shilpa Sharma on January 13, 2022 at 6:41 pm

    Dr Nik Kotecha OBE, chairman of Morningside Pharmaceuticals and the Randal Charitable Foundation, has won the Distinguished Alumni Award at Imperial College London’s Alumni Awards 2022. The annual awards honour outstanding alumni who have demonstrated sustained excellence in their personal and professional achievements and have made a substantial impact on society. Dr Kotecha, who founded The post Morningside Pharmaceuticals’ Nik Kotecha receives Distinguished Alumni Award by Imperial College London first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Free PPE for pharmacy teams extended for a further year
    by Isabel Shaw on January 13, 2022 at 4:27 pm

    Community pharmacies in England will be eligible to receive free personal protective equipment (PPE) from the Government until 31 March 2023, following the results of a public consultation. The Department of Health and Social Care (DHSC) ran the consultation in October to determine whether centrally provided PPE should end as planned in March or be... Read more The post Free PPE for pharmacy teams extended for a further year appeared first on The Pharmacist.

  • Effort to jab vulnerable communities get funding boost of £22.5 million
    by Shilpa Sharma on January 13, 2022 at 3:19 pm

    Backed by a £22.5 million of government funding, community vaccine champions will tap into their local networks and encourage people in their communities to get vaccinated against the Covid-19 (Covid-19 jab). The funding, allocated today (January 13) to 60 councils, will help deliver bespoke projects in these regions, including: In Derby and Newham roving vaccinators The post Effort to jab vulnerable communities get funding boost of £22.5 million first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Professor Sir Jonathan Van-Tam to step down as deputy chief medical officer in March
    by Shilpa Sharma on January 13, 2022 at 3:18 pm

    Professor Sir Jonathan Van-Tam has announced that he will step down as deputy chief medical officer (DCMO) for England at the end of March to take up a new role at the University of Nottingham. He joined Department of Health and Social Care (DHSC) on secondment from the university in 2017, and will soon return The post Professor Sir Jonathan Van-Tam to step down as deputy chief medical officer in March first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • England to cut minimum Covid self-isolation to five days
    by Pri Mandav on January 13, 2022 at 3:17 pm

    The minimum Covid self-isolation period in England will be cut to five days from seven if someone tests negative twice, health secretary Sajid Javid said on Thursday (January 13) — a move that could reduce staffing disruption in businesses and infrastructure. The rapid spread of the Omicron variant has fueled a spike in Covid-19 cases The post England to cut minimum Covid self-isolation to five days first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • AstraZeneca inks pact with Scorpion Therapeutics to develop medicines against cancer proteins
    by Shilpa Sharma on January 13, 2022 at 3:16 pm

    Global pharmaceutical and biotechnology company AstraZeneca has signed an agreement with Scorpion Therapeutics to discover, develop and commercialize precision medicines against cancer proteins. The collaboration, announced today (January 13), will focus on a class of proteins called transcription factors, which can regulate important cellular processes including cell growth and survival. Many transcription factors have been The post AstraZeneca inks pact with Scorpion Therapeutics to develop medicines against cancer proteins first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Nearly 9,000 pharmacy contractors benefit from earlier advance payment in January
    by Shilpa Sharma on January 13, 2022 at 3:15 pm

    Nearly 9,000 pharmacy contractors benefitted from earlier advance payment in January, Pharmaceutical Services Negotiating Committee (PSNC) said in an update. Contractors who declared their December FP34C submission figures (for the dispensed prescriptions) through the Manage Your Service (MYS) portal by January 6, would have received earlier advance payments on January 12. Meanwhile, all contractors who The post Nearly 9,000 pharmacy contractors benefit from earlier advance payment in January first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • One-third of all boosters delivered by pharmacies
    by Isabel Shaw on January 13, 2022 at 12:15 pm

    Pharmacy-led vaccine sites across England have delivered one-third of all booster vaccines, as more sites continue to be commissioned. In an update, published this morning to mark one year since the first vaccine was delivered in a pharmacy, NHS England said that community pharmacies in England had administered 22 million vaccines in total from 1,500... Read more The post One-third of all boosters delivered by pharmacies appeared first on The Pharmacist.

  • Triumphs and tribulations: a forecast for 2022
    by Oli Hudson on January 13, 2022 at 11:08 am

    As we move into an uncertain 2022, Wilmington Healthcare’s Oli Hudson picks out three underlying themes that are likely to influence the way industry works with the NHS in the next 12 months. Industry has shown itself to be extraordinarily resilient and adaptable over another gruelling 12 months – and it will surely need to

  • New UK hub launched to accelerate treatment and awareness for rare disease
    by Emma Cooper on January 13, 2022 at 10:53 am

    A new research programme dedicated to the study and treatment of rare genetic disorder, Alport syndrome, will begin work in early 2022. The Stoneygate and Kidney Research UK – Alport Research Hub aims to accelerate research, transform early diagnosis and develop specific treatments for the disease. Although Alport syndrome is a rare genetic disorder, it

  • GPhC announces new common registration assessment provider
    by Isabel Shaw on January 13, 2022 at 10:47 am

    The General Pharmaceutical Council (GPhC) has appointed a new provider to run the common registration assessment for the next three years.   From June, the common registration assessment, which is now held jointly by GPhC and the Pharmaceutical Society of Northern Ireland (PSNI), will be held by the BTL Group online.   In a statement, published on its website yesterday (12 January),... Read more The post GPhC announces new common registration assessment provider appeared first on The Pharmacist.

  • More than 40 million people are now double jabbed against Covid-19
    by Shilpa Sharma on January 12, 2022 at 7:14 pm

    The NHS Covid-19 vaccination programme has administered more than 40 million second doses following a bumper week that saw over 200,000 people coming forward for their second jab. Last week, more than 65,000 people aged 18 and over also stepped up to get their first dose of the Covid-19 jab. The NHS continued to encourage The post More than 40 million people are now double jabbed against Covid-19 first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • GPhC appoints BTL Group to conduct common registration assessment
    by Shilpa Sharma on January 12, 2022 at 7:11 pm

    The General Pharmaceutical Council (GPhC) has appointed a new provider, BTL Group Ltd, to conduct its common registration assessment sittings, which it holds jointly with the Pharmaceutical Society of Northern Ireland (PSNI). GPhC chief executive, Duncan Rudkin, said: “I’m pleased to confirm that we have appointed BTL as the supplier for the common registration assessment The post GPhC appoints BTL Group to conduct common registration assessment first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Ashfield Engage and ysuru partner to enhance HCP engagement
    by Emma Cooper on January 12, 2022 at 10:17 am

    Ashfield Engage and ysura have announced that they are partnering to transform healthcare professional (HCP) and pharma interactions in Europe through a seamless omnichannel solution. Ashfield Engage helps clients engage successfully with HCPs through a blend of sales, account management and medical science liaison teams across digital, virtual and in-person channels. ysura’s proprietary, cloud-based Customer

  • NeoCura and PhoreMost collaborate on oncology drug discovery research
    by Emma Cooper on January 11, 2022 at 10:19 am

    NeoCura, an RNA-based drug research and development company in China, and PhoreMost, the UK-based biopharmaceutical company, have announced an oncology drug discovery research collaboration. As part of the collaboration, PhoreMost’s SITESEEKER® phenotypic screening platform and NeoCura’s full-process RNA drug design platform will be used to investigate the cellular delivery and efficacy of encoded targeted peptides.

  • NICE recommends AbbVie’s Rinvoq for psoriatic arthritis patients
    by Emma Cooper on January 10, 2022 at 2:29 pm

    The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending AbbVie’s RINVOQ® ▼ (upadacitinib), as a new option for treating adults with active psoriatic arthritis (PsA). PsA is a systemic inflammatory disease with hallmark manifestations across multiple domains including joints and skin. In psoriatic arthritis, the immune system

  • NICE announces new Chief Executive
    by Emma Cooper on January 7, 2022 at 9:41 am

    The National Institute for Health and Care Excellence (NICE) Chairman, Sharmila Nebhrajani, has announced Dr Samantha Roberts as incoming Chief Executive. Dr Roberts has more than 20 years’ experience of healthcare having worked in service delivery, consultancy and as a clinician. She joined NHS England in 2018, as Director of Innovation, Research and Life Sciences.

  • 2021: Reflections on a year in pharma
    by Chinmay Bhatt on January 6, 2022 at 11:07 am

    Following his first full year as Managing Director of Novartis UK, Ireland & Nordics and Country President UK for Novartis Pharmaceuticals, healthcare leader Chinmay Bhatt shares his reflections on 2021. As we enter this new year, I have been reflecting on the particular challenges and opportunities that presented themselves in the last 12 months. COVID-19

  • Ashfield Engage partners with Alliance Medical to identify early-stage lung cancer
    by Emma Cooper on January 6, 2022 at 10:56 am

    Ashfield Engage, part of UDG Healthcare, has partnered with Alliance Medical and the NHS to forge a new collaboration delivering the Targeted Lung Health Check (TLHC) programme. The programme is running across 12 pilot sites across the UK and is driven by NHS England cancer care roadmap, aiming to identify and treat people with early

  • Psilocybin study shows promise as treatment for mental health conditions
    by Emma Cooper on January 5, 2022 at 10:37 am

    A study conducted by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in association with COMPASS Pathways, has demonstrated feasibility of simultaneous administration of COMP360 psilocybin in a controlled setting to healthy participants with 1:1 therapist support. The study, peer-reviewed and published in The Journal of Psychopharmacology as “The effects of psilocybin

  • MHRA approves Pfizer’s COVID-19 antiviral treatment Paxlovid
    by Emma Cooper on January 4, 2022 at 2:50 pm

    The Medicines and Healthcare products Regulatory Agency (MHRA) has approved COVID-19 antiviral treatment, Paxlovid (PF-07321332 and ritonavir), after it was found to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 infection who are at an increased risk of developing severe disease. Developed by Pfizer,

  • UK marks 132 million COVID-19 vaccinations in 2021
    by Emma Cooper on January 4, 2022 at 11:21 am

    Around 132 million COVID-19 vaccinations were administered across all four nations of the UK in 2021, as part of the largest vaccination programme in British history. It marks the end of a monumental year for the NHS, with over 1.6 million people in the UK receiving a booster or third dose in the final week

  • Future proofing employee skills
    by David Reilly on January 4, 2022 at 9:00 am

    As pharma employees start returning to the workplace, David Reilly examines key learnings from in-house educators and reflects on how pharma can re-augment staff skills for the future digitally enabled customer experience. Imagine a seminal crisis that forces your workforce to shift overnight to working from home and adapt to a suite of new unfamiliar digital

  • From policy to practice: get ahead of the curve in 2022
    by Oli Hudson on December 30, 2021 at 9:00 am

    As the curtain drops on another remarkable 12 months, what are the four critical challenges that industry needs to prepare for in 2022? 1. New structures Undoubtedly, 2021 was the year in which hypothetical changes became physical reality. There are now 42 integrated care systems (ICSs) in operation, all of which are slowly devouring the

  • Meet the manager: Gulfam Wali
    by Emma Cooper on December 29, 2021 at 9:00 am

    Bayer’s Gulfam Wali, winner of the Outstanding Management Award Pf Awards 2021 on his passion for leadership and how managing a team through such a tough time has inspired him. Congratulations on your Pf Awards win. How did you feel when your name was announced? It was amazing. Reaching the finals was a great honour and

  • From Business Director to Medical Director
    by Emma Cooper on December 28, 2021 at 9:00 am

    Stuart Hill, previously Business Unit Director for Oncology at Merck, was recently promoted to Medical Director for the UK and Ireland. Here, he talks to Pf about his career transition. How did you begin your career in the pharmaceutical industry? I joined the industry straight after graduating from my Ph.D. in a field sales role

  • A career in pharmacy: Variety & impact
    by Emma Cooper on December 24, 2021 at 9:00 am

    Helen Porter, Pharmacy Dean London and South East, Health Education England, shares why a career in pharmacy has so much to offer. Tell us about your pharmacy career so far My career started in hospital, working as part of a multi-disciplinary team (MDT) providing care to patients with long-term illnesses. The needs of these patients

  • E4H Acquired by Uniphar, a Global Diversified Healthcare Services Business
    by Emma Morriss on December 23, 2021 at 9:15 am

    Brand commercialisation and pharmaceutical marketing agency, E4H, has been acquired by Uniphar Plc. Uniphar is a trusted global partner to pharma and Medtech manufacturers. Uniphar provides specialised outsourced services to its clients, generating revenue of c€2bn through a workforce of over 3,200 people across Ireland, the UK, Benelux, the Nordics, Germany and the US. E4H, as a business unit, will sit within the

  • Under the microscope: A career in science
    by Emma Cooper on December 23, 2021 at 9:00 am

    Pf talks to Martyn Hiscox, Principal Scientist in the phage display group at Display Technologies.  Did you always have a strong interest in science at school? I was always interested in how things worked and why the world was like it is. My mother would always remark that as a child I never read fiction, it

  • Evolving through the year
    by Colin Prentice on December 23, 2021 at 9:00 am

    As 2021 draws to a close, Colin Prentice, Commercial Director at Evolve, reflects on a year in recruitment. I’m sure many of us can’t quite believe we are drawing towards the end of another year. I certainly can’t, as the past few months have flown. My role with Evolve started in April 2021 and since then

  • New Licensed Version of Alimemazine 10mg/5ml Oral Sol. S/f
    by Greg Bull on December 17, 2021 at 9:42 am

    Don’t Forget to Sign Up for the Rebate Scheme! A new strength of alimemazine oral solution sugar free 10mg/5mL is

  • Clawback Explained
    by Greg Bull on November 23, 2021 at 6:59 pm

    Dispensing Doctor reimbursement has, for at least the past 25 years, included an element known as “Clawback”. The technical name

  • Where Are Your Prescriptions Being Dispensed?
    by Greg Bull on November 15, 2021 at 8:18 pm

    Dispensing Matters by Greg Bull I have been curious about the impact that Covid-19 has had on dispensing doctors for

  • Maximize Space and Efficiency in Your Dispensary
    by Greg Bull on November 15, 2021 at 4:56 pm

    We have known Richard Kay for many years and his company Pharma Storage Solutions have been refitting dispensing doctor dispensaries

  • FAQs, VAT, Your Invoices and Your Reporting
    by Greg Bull on November 15, 2021 at 4:47 pm

    PA Items and Your Invoices Explained By Alastair Carmichael MRPharmS and Greg Bull Question: I am going through my notes

  • Drug Tariff Additions November 2021
    by Greg Bull on October 13, 2021 at 10:25 am

    The October 2021 preface includes those products which are going to be added for the November 2021 Drug tariff, meaning

  • Dispensing Fee Drops Dramatically
    by Greg Bull on October 7, 2021 at 4:03 pm

    The new dispensing fee for the period October 2021 to April 2022 has been released with a drop in the

  • PAMAN and dispensing practices – creating a paradigm shift in medication adherence
    by Greg Bull on September 20, 2021 at 3:33 pm

    Putting dispensing practices at the forefront of change in Primary care The PAMAN System and Service A remote monitoring, medication

  • NEW Drug Tariff Section; What You Need to Know
    by Greg Bull on September 7, 2021 at 12:46 pm

    Last week the BBC news reported here on the NHS deal on the product inclisiran (Leqvio) 284mg/1.5ml solution for injection

  • Don’t Lose Out; Generics Which Cost More Than Drug Tariff
    by Greg Bull on August 4, 2021 at 10:08 am

    As every dispenser knows, the purchase price of generics can vary month on month and from supplier to supplier. So

  • Influencing Skills
    by Pharmaceutical Services Negotiating Committee on June 29, 2018 at 12:00 pm

    In this PSNC podcast we explore how to learn and use influencing skills to promote community pharmacy in the changing commissioning environment. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • Change management
    by Pharmaceutical Services Negotiating Committee on June 1, 2017 at 11:09 am

    As the NHS continues to change, LPCs need to be able to adapt to the changes and support contractors in changing times. This podcast discusses how to manage change both within and outside the LPC. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide)....

  • How to be a mentor
    by Pharmaceutical Services Negotiating Committee on May 31, 2017 at 10:47 am

    Learn more about mentoring, an adaptable skill that can be used within community pharmacy and beyond. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • Negotiation skills
    by Pharmaceutical Services Negotiating Committee on November 7, 2016 at 4:53 pm

    Led by negotiation skills trainer Phil Parry this PSNC MyCoach podcast provides tips on how to avoid failure and improve success. Supported by Pfizer Limited. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • Facilitation skills
    by Pharmaceutical Services Negotiating Committee on November 4, 2016 at 2:42 pm

    Facilitating an LPC planning meeting  or contractor meeting? This  short PSNC MyCoach podcast will sharpen skills and boost your confidence. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • Chairing meetings
    by Pharmaceutical Services Negotiating Committee on November 3, 2016 at 12:52 pm

    For new LPC chairs or experienced chairs looking for tips and ideas – a PSNC MyCoach podcast on chairing meetings, with training consultant Phil Parry. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • LPCs and market entry applications
    by Pharmaceutical Services Negotiating Committee on July 6, 2016 at 10:01 am

    In this PSNC podcast we discuss why LPCs are consulted on market entry applications; what if the applicant is not an existing contractor in the LPC area; what LPCs should and shouldn’t take into account when considering an application; what about distance selling applications; governance and conflicts of interests? Listen to more of our podcasts...

  • Leadership
    by Pharmaceutical Services Negotiating Committee on July 4, 2016 at 12:18 pm

    With Rachel Harrison who leads PSNC’s Leadership Academy. Rachel discusses the qualities she has seen in some of the LPC members and officers that single them out as potential leaders. The qualities LPC leaders possess; what make people follow leaders? Key aspects of change management and coaching; the different styles of leadership? What sort of...

  • Contract monitoring – CPAF
    by Pharmaceutical Services Negotiating Committee on July 1, 2016 at 8:31 am

    Find out about the way the Community Pharmacy Assurance Framework (CPAF) – is there an obligation to complete it? The questions that are asked and how to complete them; how long do pharmacies have to return them – is there flexibility? What happens if a pharmacy doesn’t complete it? When the report has been submitted,...